<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:56:45Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18349" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18349</identifier><datestamp>2026-10-18T20:56:31Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Determination of Cardiac Involvement of Sarcoidosis with  Cardiac MR, ECHO, and Holter ECG</dc:title><dc:creator>Tosun, Mustafa</dc:creator><dc:creator>Keskin, Suat</dc:creator><dc:creator>Akilli, Hakan</dc:creator><dc:creator>Kayrak, Mehmet</dc:creator><dc:creator>Yeşildağ, Ahmet</dc:creator><dc:creator>Uzun, Kursat</dc:creator><dc:subject>Mikroskopi</dc:subject><dc:subject>Tıbbi Araştırmalar Deneysel</dc:subject><dc:subject>Anestezi</dc:subject><dc:subject>Genel ve Dahili Tıp</dc:subject><dc:subject>Patoloji</dc:subject><dc:subject>Nörolojik Bilimler</dc:subject><dc:subject>Kalp ve Kalp Damar Sistemi</dc:subject><dc:description>Objective: Sarcoidosis is a systemic granulomatous disease  of unknown origin, which principally affects lungs and lym phatic system. Cardiac involvement is rarely seen in sarcoidosis  patients, it is important as it causes fatal outcomes. Early detec tion of cardiac involvement in sarcoidosis is important, and early  initiation of treatment may affect the prognosis. In this study,  we aimed to determine the frequency of cardiac involvement  in sarcoidosis cases with late gadolinium enhancement car diac magnetic resonance (CMR) studies, echocardiography, and  Holter electrocardiogram.  Methods: Forty-nine cases with sarcoidosis were planned to  enroll this study. Female/male ratio of the enrolled patients was  6,1, and their mean age was 46,3 ± 10,6 years. A 24-hour Holter  recording and echocardiography were performed to the patients.  After these procedures, delayed gadolinium involvement was  observed in CMR, by administering intravenous gadolinium.  Results: Gadolinium involvement in magnetic resonance imag ing (MRI) was detected in 16 (33%) of 49 cases. There was no  significant difference according to Holter records due to cardiac  involvement in sarcoidosis. Diastolic functions were deteriorated in  echocardiography in patients with MRI involvement.  Conclusion: We can say that delayed gadolinium involvement in  magnetic resonance is a usable imaging with high specifity and sensitivity in cardiac involvement of sarcoidosis. This imaging  method should take place especially among patients with sar coidosis for diagnosis of cardiac involvement.</dc:description><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/18349</dc:identifier><dc:identifier>https://doi.org/10.54614/abcr.2022.21028</dc:identifier><dc:identifier>2687-4520</dc:identifier><dc:language>tr</dc:language><dc:relation>Archives of Basic and Clinical Research</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18349</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>